HealthDay News — Products marketed as selective androgen receptor modulators and sold via the internet frequently contain unapproved drugs and substances, and the amount of active compound often does ...

A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the male sex hormone receptor ...

A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the male sex hormone receptor ...

The study will include around 200 participants aged 65 or older with BMI of at least 35 starting semaglutide therapy.

Co announces that it has licensed from Bristol-Myers Squibb (BMY) a selective androgen receptor modulator program, including a lead compound in Phase 1 clinical development and back-up compounds.

Impact of BMI on CDK4/6 inhibitors efficacy and safety in advanced breast cancer: Results from a propensity score matched study—CAMELIA. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Testing the cutaneous absorption of lorazepam, diphenhydramine, and haloperidol gel (ABH gel) used for cancer-related nausea. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This ...

Always on the lookout for unapproved drugs and supplements being sold, the U.S. Food and Drug Administration (FDA) has ramped up its enforcement actions against selective androgen receptor modulators ...

Co announces data from a preclinical study on its Selective Androgen Receptor Modulator LGD-3303 at the American Society for Bone and Mineral Research Annual Meeting in Honolulu, Hawaii on Sept 16, ...